We have designed and studied a new class of fusion proteins carrying NGR peptides instead of the transmembrane domain at the C-terminus of truncated tissue factor (tTF) to induce tumor vascular thrombosis and occlusion with subsequent infarction [13,14,15,16,17,18,19,20]. This evidence concerns the gene RTN4R and neoplasm.